Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022

This article was originally published on Microdose and appears here with permission.

Benzinga

FDA revokes approval for Covid antibody drugs that don’t work against Omicron prompting DeSantis pushback

Florida governor pushes back against decision, calling it ‘sudden and reckless’

The Independent UK

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder

The FDA has

Benzinga

FDA limits use of Regeneron and Lilly COVID antibody treatments

The FDA said "data show these treatments are highly unlikely to be active" against Omicron.

Axios

FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why

Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY) are not likely to work against the Omicron variant of COVID-19 and their emergency use authorization has been rescin

Benzinga

News briefs

FDA halts use of 2 treatments found to be ineffective against omicron

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

FDA halts use of 2 treatments found to be ineffective against omicron

WASHINGTON — U.S. regulators restricted the use of a pair of COVID-19 monoclonal antibody therapies after scientific evidence suggested they are unlikely to be effective against the omicron variant.

Tribune News Service

FDA halts use of antibody drugs that don't work vs. omicron

U.S. health officials say COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant

The Independent UK

Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA

The

Benzinga

FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors

The

Benzinga

FDA Gives Nod To TScan Therapeutics' Early-Stage Trial Of TSC-100 In Hematologic Malignancies

The

Benzinga

Ionis' Eplontersen Receives FDA Orphan Drug Status For Misfolded Protein Disorder

The

Benzinga

Soleno Concludes Type C Meeting With FDA For Diazoxide Choline In Prader-Willi Syndrome

Soleno Therapeutics Inc (NASDAQ: SLNO) said that on January 20, 2022, the Company

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Bangkok Post

Legalisation of household cannabis, limited recreational use

The Food and Drug Administration (FDA) drafted a bill to legalise the household cultivation and consumption of cannabis and its recreational use in some locations.

The Independent UK

DeSantis still won’t say if he’s had booster after Trump accused politicians of being ‘gutless’ for secrecy

Donald Trump and Ron DeSantis, both 2024 frontrunners, have traded barbs in recent weeks

Input

Neuralink is gearing up for human trials despite lacking FDA approval

Elon Musk's brain-computer interface company still hasn't been given the go-ahead to test its implants on humans.

Chicago Sun-Times

Ask the Doctors: New FDA guidance asks food manufacturers to cut salt in their products

It’s targeting food manufacturers, restaurants and other vendors of prepared foods in an effort to help reduce how much sodium Americans consume.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Elanco's Long-Acting Transdermal Buprenorphine for Cats Gains FDA Approval

The

Benzinga

FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial

The

Tribune News Service

Elon Musk’s brain implant company is inching toward human trials

Elon Musk’s brain implant company Neuralink is now hiring a clinical trial director, an indication that the company’s longstanding goal of implanting chips in human brains is coming closer.

Birmingham Post

Tech pioneer PolyPhotonix secures $10m investment to take sight-saving masks into US market

Prevail Partners LLC has agreed to invest significantly in NETPark based PolyPhotonix

Benzinga

FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting

The

Benzinga

FDA Gives Green Signal To Compass Therapeutics' Mid-Stage Biliary Tract Cancer Trial In US

The

1 … 237 238 239 240

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Regeneron Pharmaceuticals Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.